Abd-Aziz N,Stanbridge EJ,Shafee N .2016 .Newcastle disease virus degrades HIF-1α through proteasomal pathways independent of VHL and p53. J General Virol, 97 : 3174-3182.
Adelfinger M,Bessler S,Frentzen A .2015 .Preclinical testing oncolytic vaccinia virus strain glv-5b451 expressing an anti-vegf single-chain antibody for canine cancer therapy. Viruses, 7 : 4075-4092.
Ahmad U,Ahmed I,Keong YY .2015 .Inhibitory and apoptosisinducing effects of newcastle disease virus strain af2240 on mammary carcinoma cell line. , : .
Ahmed I,Ahmad U,Keong YY .2014 .Induction of nitric oxide and TNF-Α in Newcastle disease virus (NDV) AF2240 infected RAW 264.7 macrophages and their cytotoxic activity on MDA-MB-231 breast cancer cell line. J Cancer Sci & Therapy, 6 : 1.
Al-Shammari AM,Abdullah AH,Allami ZM .2019 .-Deoxyglucose and Newcastle Disease Virus Synergize to Kill Breast Cancer Cells by Inhibition of Glycolysis Pathway Through Glyceraldehyde3- Phosphate Downregulation. Front Mol Biosci, 6 : 90.
Al-Shammari AM,Al-Mudhafr MA,Al-Grawi EDC .2022 .Newcastle disease virus suppresses angiogenesis in mammary adenocarcinoma models. Bulgarian J Vet Med., : .
Al-Ziaydi AG,Al-Shammari AM,Hamzah MI .2020 .Hexokinase inhibition using D Mannoheptulose enhances oncolytic Newcastle disease virus-mediated killing of breast cancer cells. Cancer Cell International, 20 : 1-10.
Amin ZM,Ani MAC,Tan SW .2019 .Evaluation of a recombinant Newcastle Disease virus expressing human IL12 against human breast cancer. Scientific Reports, 9 : .
Burke S,Shergold A,Elder MJ .2020 .Oncolytic Newcastle Disease virus activation of the innate immune response and priming of antitumor adaptive responses in vitro. Cancer Immunology. Immunotherapy, 69 : 1015-1027.
Cejalvo T,Perisé-Barrios Del Portillo I,Laborda E .2018 .Remission of spontaneous canine tumors after systemic cellular viroimmunotherapy. Cancer Res, 78 : 4891.
Cekanova M and Rathore K .2014 .Animal models and therapeutic molecular targets of cancer: utility and limitations. Drug Design, Development and Therapy, 8 : 1911-1921.
Chambers P,Millar NS,Bingham RW .1986 .Molecular cloning of complementary DNA to newcastle disease virus, and nucleotide sequence analysis of the junction between the genes encoding the haemagglutinin-neuraminidase and the large protein. J General Virol, 67 : 475-486.
Cuadrado-Castano S,Ayllon J,Mansour M .2015 .Enhancement of the proapoptotic properties of Newcastle disease virus promotes tumor remission in syngeneic murine cancer models. Molecular Cancer Therapeutics, 14 : 1247-1258.
Das A,Shafiuzama M,Tirumurugaan KG .2017 .Therapeutic potential of ndv-2k17 strain in canine mammary gland tumor. Int J Chemical Studies, 5 : 605-609.
Dimitrov KM,Ramey AM,Qiu X .2016 .Temporal, geographic, and host distribution of avian paramyxovirus 1 (Newcastle disease virus). Infection, Genetics and Evolution, 39 : 22-34.
Dortmans JC,Koch G,Rottier J .2011 .Virulence of Newcastle disease virus: what is known so far? Vet Res 42. , : .
Elankumaran S,Chavan V,Qiao D .2010 .Type I interferonsensitive recombinant Newcastle disease virus for oncolytic virotherapy. J Virol, 84 : 3835.
Elankumaran S,Rockemann D,Samal SK .2006 .Newcastle disease virus exerts oncolysis by both intrinsic and extrinsic caspasedependent pathways of cell death. J Virol, 80 : 7522-7534.
Freeman AI,Zakay-Rones Z,Gomori JM .2006 .Phase I/II trial of intravenous NDV HUJ oncolytic virus in recurrent glioblastoma multiforme. Mol Therapy, 13 : 221-228.
Frey SE,Newman FK,Cruz J .2002 .Dose-related effects of smallpox vaccine. The New England J Med, 346 : 1275-80.
Ganar K,Das M,Sinha S .2014 .Newcastle disease virus: current status and our understanding. Vir Res, 184 : 71-81.
Gómez A,Sardón D,Cejalvo T .2020 .Biodistribution analysis of oncolytic adenoviruses in canine patient necropsy samples treated with cellular virotherapy. Molecular Therapy - Oncolytics, 18 : 525-534.
Hegde S,Karanikas V,Evers S .2016 .The where, the when, and the how of immune monitoring for cancer immunotherapies in the era of checkpoint inhibition. Clinical Cancer Res, 22 : 1865-1874.
Ilyinskaya GV,Mukhina EV,Soboleva AV .2018 .Oncolytic sendai virus therapy of canine mast cell tumors (a pilot study). Frontiers in Vet Sci, 5 : 16.
Iizuka K,Shoji K,Fujiyuki T .2020 .Antitumor activity of an oncolytic measles virus against canine urinary bladder transitional cell carcinoma cells. Res Vet Sci, 133 : 313-317.
Jamal MH,Ch'ng WC,Yusoff K .2012 .Reduced Newcastle disease virus-induced oncolysis in a subpopulation of cisplatin-resistant MCF7 cells is associated with survivin stabilization. Cancer Cell International, 12 : .
Ji Y,Liu T,Jia Y .2017 .Two single mutations in the fusion protein of Newcastle disease virus confer hemagglutinin-neuraminidase independent fusion promotion and attenuate the pathogenicity in chickens. Virology, 509 : 146-151.
Jin K,Tao X,Fan Y .2021 .Crosstalk between oncolytic viruses and autophagy in cancer therapy. Biomedicine & Pharmacotherapy, 134 : .
Kalid M,Jahanshiri F,Omar AR .2010 .Gene expression profiling in apoptotic MCF-7 cells infected with Newcastle Disease virus. Global Veterinaria, 5 : 334-340.
Kalyanasundram J,Hamid A,Yusoff K .2018 .Newcastle disease virus strain AF2240 as an oncolytic virus: a review. Acta Tropica, 183 : 126-133.
Karcher J,Dyckhoff G,Beckhove P .2004 .Antitumor vaccination in patients with head and neck squamous cell carcinomas with autologous virus-modified tumor cells. Cancer Res, 64 : 8057-8061.
Keshavarz M,Nejad ASM,Esghaei M .2020 .Oncolytic Newcastle disease virus reduces growth of cervical cancer cell by inducing apoptosis. Saudi J Biol Sci, 27 : 47-52.
King JN .2017 .Master of Science in Biomedical and Veterinary Sciences, Faculty of the Virginia Polytechnic Institute. , : .
Lam HY,Yeap SK,Rasoli M .2011 .Safety and clinical usage of Newcastle disease virus in cancer therapy. BioMed Research, : .
Lam HY,Yusoff K,Yeap SK .2014 .Immunomodulatory effects of Newcastle disease virus AF2240 strain on human peripheral blood mononuclear cells. Int J Med Sci, 11 : 1240-1247.
Lamb RA,Parks GD,Knipe DM,Howley M .2007 .Paramyxoviridae: the viruses and their replication. In: Fields Virology (Fields BN, : 1449-1496.
Laurie SA,Bell JC,Atkins HL .2006 .A phase 1 clinical study of intravenous administration of PV701, an oncolytic virus, using two-step desensitization. Clinical Cancer Res, 12 : 2555-62.
Liu T,Zhang Y,Cao Y .2021 .Optimization of oncolytic effect of Newcastle disease virus Clone30 by selecting sensitive tumor host and constructing more oncolytic viruses. Gene Therapy, 28 : 697-717.
MacNeill AL,Weishaar KM,Séguin B .2018 .Safety of an oncolytic myxoma virus in dogs with soft tissue sarcoma. Viruses, 10 : 398.
Mahalingam D,Fountzilas C,Moseley J .2017 .A phase II study of REOLYSIN® (pelareorep) in combination with carboplatin and paclitaxel for patients with advanced malignant melanoma. Cancer Chemother Pharmacol, 79 : 697-703.
Marelli G,Howells A,Lemoine NR .2018 .Oncolytic viral therapy and the Immune System: a double-edged sword against cancer. Frontiers in Immunology 9., : .
Martini V,D'avanzo F,Maggiora M .2020 .Oncolytic virotherapy: new weapon for breast cancer treatment. Ecancermedicalscience, 14 : 1-19.
Meyyappan N .2003 .Oncolytic effect of Newcastle disease virus on the MCF-7 and MDAMB-231 breast cancer cell lines. Universiti Putra Malaysia., : .
Molouki A,Peeters B .2017 .Rescue of recombinant Newcastle disease virus: current cloning strategies and RNA polymerase provision systems. Archives of Virology, 162 : 1-12.
Naik S,Galyon GD,Jenks NJ .2018 .Comparative oncology evaluation of intravenous recombinant oncolytic vesicular stomatitis virus therapy in spontaneous canine cancer. Mol Cancer Therapeutics, 17 : 316-326.
Nelson NJ .1999 .Scientific interest in Newcastle Disease virus is reviving. JNCI J Nat Cancer Institute, 91 : 1708-1710.
Nishiya AT,Massoco CO,Felizzola CR .2016 .Comparative aspects of canine melanoma. Vet Sci, 3 : .
Niu Z,Bai F,Sun T .2015 .Recombinant newcastle disease virus expressing IL15 demonstrates promising antitumor efficiency in melanoma model. Technology in Cancer Res & Treatment, 14 : 607-615.
Othman F,Ideris A,Motalleb G .2010 .Oncolytic effect of Newcastle Disease virus AF2240 strain on the MCF-7 breast cancer cell line. Yakhteh, 12 : 17-24.
Pecora AL,Rizvi N,Cohen GI .2002 .Phase I trial of intravenous administration of PV701, an oncolytic virus, in patients with advanced solid cancers. J Clinical Oncology, 20 : 2251-66.
Puff C,Krudewig C,Imbschweiler I .2009 .Influence of persistent canine distemper virus infection on expression of RECK, matrixmetalloproteinases and their inhibitors in a canine macrophage/monocytic tumour cell line (DH82). The Vet J, 182 : 100-107.
Raihan J,Ahmad U,Yong YK .2019 .Regression of solid breast tumours in mice by Newcastle disease virus is associated with production of apoptosis related-cytokines. BMC Cancer, 19 : 315.
Ramamurthy N,Pathak DC,D'Silva AL .2021 .Evaluation of the oncolytic property of recombinant Newcastle disease virus strain R2B in 4T1 and B16-F10 cells in-vitro. Res Vet Sci, 139 : 159-165.
Salas Y,Márquez A,Diaz D .2015 .Epidemiological Study of Mammary Tumors in Female Dogs Diagnosed during the Period 2002-2012: A Growing Animal Health Problem. PLOS ONE 10., : .
Sánchez D,Cesarman-Maus G,Amador-Molina A .2018 .Oncolytic viruses for canine cancer treatment. Cancers, 10 : 1.
Sánchez D,Pelayo R,Medina L .2016 .Newcastle Disease virus: potential therapeutic application for human and canine lymphoma. Viruses, 8 : .
Santos MR,Xavier LP,Pires RL .2021 .Oncolytic effect of Newcastle disease virus is attributed to interferon regulation in canine mammary cancer cell lines. Vet Comparative Oncology, 19 : 593-601.
Sarver AL,Makielski KM,DePauw TA .2022 .Increased risk of cancer in dogs and humans: A consequence of recent extension of lifespan beyond evolutionarily determined limitations?. Aging Cancer, 3 : 3-19.
Schirrmacher V,Stücker W,Lulei M . .2015b. Long-term survival of a breast cancer patient with extensive liver metastases upon immune. virotherapy: a case report. Immunotherapy, 7 : 855-60.
Schirrmacher V,Van Gool V,Stuecker W .2019 .Breaking therapy resistance: an update on oncolytic Newcastle Disease virus for improvements of cancer therapy. Biomedicines, 7 : .
Shan P,Tang B,Xie S .2021 .NDV-D90 inhibits 17 β-estradiolmediated resistance to apoptosis by differentially modulating classic and nonclassic estrogen receptors in breast cancer cells. J Cellular Biochem, 122 : 3-15.
Shobana R,Samal SK,Elankumaran S .2013 .Prostate-specific antigen-retargeted recombinant newcastle disease virus for prostate cancer virotherapy. J Virol, 87 : 3792.
Singh P,Destito G,Schneemann A .2006 .Canine parvovirus-like particles, a novel nanomaterial for tumor targeting. J Nanobiotechnology, 13 : 2.
Sinkovics J .1957 .Studies on the biological characteristics of the newcastle disease virus (NDV) adapted to the brain of newborne mice. Archiv für die gesamte Virusforschung, 7 : 403-411.
Song H,Zhong L,He J .2019 .Application of Newcastle disease virus in the treatment of colorectal cancer. World J Clinical Cases, 7 : 2143-2154.
Stephens T .2019 .The use of chemotherapy to prolong the life of dogs suffering from cancer: the ethical dilemma. Animals (Basel), 9 : 441.
Wang J,Chen H,Dai S .2022 .Immunotherapy combining tumor and endothelium cell lysis with immune enforcement by recombinant MIP-3α Newcastle disease virus in a vessel-targeting liposome enhances antitumor immunityJournal for ImmunoTherapy of Cancer. , : .
Wang SL,Lee JJ,Liao AT .2016 .Comparison of efficacy and toxicity of doxorubicin and mitoxantrone in combination chemotherapy for canine lymphoma. The Canadian veterinary journal. La revue veterinaire Canadienne, 57 : 271-276.
.2020 .Cancer today. Data source: GLOBOCAN 2020, : .
.2020 .Cancer today. Data source: GLOBOCAN, : .
Yurchenko KS,Zhou P,Kovner AV .2018 .Oncolytic effect of wild-type Newcastle disease virus isolates in cancer cell lines in vitro and in vivo on xenograft model. PLOS ONE 13., : .
Zhao H,Janke M,Fournier P .2008 .Recombinant Newcastle Disease virus expressing human interleukin-2 serves as a potential. , : .